<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01414088</url>
  </required_header>
  <id_info>
    <org_study_id>EBP-JMJ-2011-1</org_study_id>
    <nct_id>NCT01414088</nct_id>
  </id_info>
  <brief_title>The Effects of Isotonic and Hypertonic Saline Infusion on Renal Biomarkers in Healthy Young Subjects</brief_title>
  <acronym>NARA</acronym>
  <official_title>The Effects of Isotonic and Hypertonic Saline Infusion on Renal Biomarkers for the Measurement of Sodium and Water Channel Activity in the Nephron in Healthy Young Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Regional Hospital Holstebro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Regional Hospital Holstebro</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The kidneys have numerous salt and water channels and play a major role in the regulation of
      sodium and water. We do not know how these channels work in certain water and sodium
      accumulating medical conditions.

      The purpose of this study is to identify and measure the activity in the water and sodium
      channels by measuring urine biomarkers/proteins in young healthy subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      25 healthy subjects from age 18-45 are recruited.

      Subjects will be examined on three examination days. Four days prior to the examination days
      the subjects will consume a standard diet based on the amount of sodium and calories.

      On the examination day subjects are randomised to an infusion with either isotonic saline 23
      ml/kg, hypertonic saline 7 ml/kg or glucose 23 ml/kg for a period of 50 minutes.

      Renal function is measured by renal clearance of 51Cr-EDTA, urinary sodium, potassium and
      creatinine.

      Urinary NCC, NKCC and ENAC will be measured to evaluate the activity of sodium channels in
      the nephron.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Renal biomarkers</measure>
    <time_frame>day one</time_frame>
    <description>Urinary epithelial sodium channels (ENaC), Sodium-Chloride transporters (NCC), Sodium-potassium-2chloride transporters (NKCC) and aquaporin2 channels (AQP2) before, during and after fluid infusion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood hormones regulating salt, water and blood pressure</measure>
    <time_frame>day one</time_frame>
    <description>plasma concentrations of: renin, Angiotensin II, Vasopressin, atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Nephropathy</condition>
  <arm_group>
    <arm_group_label>glucose</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>glucose 5 %</description>
  </arm_group>
  <arm_group>
    <arm_group_label>isotonic saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>isotonic saline 0.9 mg/ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>hypertonic saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>hypertonic saline 2.9 mg/ml</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>isotonic saline 0,9 mg/ml</intervention_name>
    <description>infusion, 23 ml/kg, during 50 minutes</description>
    <arm_group_label>isotonic saline</arm_group_label>
    <other_name>isotonic saline</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>hypertonic saline 2,9 mg/ml</intervention_name>
    <description>infusion, 7 ml/kg, during 50 minutes</description>
    <arm_group_label>hypertonic saline</arm_group_label>
    <other_name>hypertonic saline</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>glucose 5%</intervention_name>
    <description>infusion, 23 ml/kg, during 50 minutes</description>
    <arm_group_label>glucose</arm_group_label>
    <other_name>glucose 5 %</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy males and females

          -  age 18-45

          -  BMI range 18,5-30,0 kg/m2

        Exclusion Criteria:

          -  hypertension (ie ambulatory BP &gt;130 mmHg systolic or/and &gt;80 mmHg diastolic)

          -  history or clinical significant signs of heart, lung, liver, kidney, endocrine, brain
             or neoplastic disease.

          -  alcohol abuse

          -  drug abuse

          -  smoking

          -  pregnancy or nursing

          -  blood donation within a month prior to examination

          -  Medical treatment apart from oral contraception
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erling B Pedersen, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Medicinsk Forskning, Regionshospitalet i Holstebro</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medicinsk Forskning, Regionshospitalet i Holstebro</name>
      <address>
        <city>Holstebro</city>
        <zip>7500</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 9, 2011</study_first_submitted>
  <study_first_submitted_qc>August 10, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2011</study_first_posted>
  <last_update_submitted>May 17, 2013</last_update_submitted>
  <last_update_submitted_qc>May 17, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 20, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Regional Hospital Holstebro</investigator_affiliation>
    <investigator_full_name>Erling Bjerregaard Pedersen</investigator_full_name>
    <investigator_title>DMSc</investigator_title>
  </responsible_party>
  <keyword>Nephrology</keyword>
  <keyword>ENaC</keyword>
  <keyword>NCC</keyword>
  <keyword>NKCC</keyword>
  <keyword>Sodium channels</keyword>
  <keyword>renal biomarkers</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

